Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Non Operating Income (2023 - 2025)

Cyclerion Therapeutics has reported Other Non Operating Income over the past 3 years, most recently at $30000.0 for Q3 2025.

  • For Q3 2025, Other Non Operating Income fell 28.57% year-over-year to $30000.0; the TTM value through Sep 2025 reached $117000.0, down 58.36%, while the annual FY2024 figure was $208000.0, 41.9% down from the prior year.
  • Other Non Operating Income for Q3 2025 was $30000.0 at Cyclerion Therapeutics, down from $31000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $107000.0 in Q3 2023 and troughed at $28000.0 in Q4 2024.
  • A 3-year average of $56111.1 and a median of $42000.0 in 2024 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: crashed 72.28% in 2024 and later dropped 28.57% in 2025.
  • Year by year, Other Non Operating Income stood at $101000.0 in 2023, then crashed by 72.28% to $28000.0 in 2024, then increased by 7.14% to $30000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for CYCN at $30000.0 in Q3 2025, $31000.0 in Q2 2025, and $28000.0 in Q1 2025.